MedPath

上海寿如松药业泌阳制药有限公司

Ownership
-
Established
2003-06-01
Employees
-
Market Cap
-
Website
http://srszy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

106

NMPA:106

Drug Approvals

Enalapril Maleate Tablets

Product Name
马来酸依那普利片
Approval Number
国药准字H20143383
Approval Date
Dec 2, 2022
NMPA

Licorzine

Product Name
甘草锌
Approval Number
国药准字H41024603
Approval Date
Jan 15, 2021
NMPA

Rutin

Product Name
芦丁
Approval Number
国药准字H41022326
Approval Date
Jan 15, 2021
NMPA

Troxerutin

Product Name
曲克芦丁
Approval Number
国药准字H41024608
Approval Date
Jan 15, 2021
NMPA

Indometacin

Product Name
吲哚美辛
Approval Number
国药准字H41022327
Approval Date
Sep 24, 2020
NMPA

Pentoxyverine Citrate

Product Name
枸橼酸喷托维林
Approval Number
国药准字H41023568
Approval Date
Sep 24, 2020
NMPA

Isoniazid Tablets

Product Name
异烟肼片
Approval Number
国药准字H41022554
Approval Date
Jul 16, 2020
NMPA

Rutin Tablets

Product Name
芦丁片
Approval Number
国药准字H41022807
Approval Date
Jul 16, 2020
NMPA

Troxerutin and Proxyphylline Tablets

Product Name
曲克芦丁羟丙茶碱片
Approval Number
国药准字H41024611
Approval Date
Jul 16, 2020
NMPA

Sucralfate Chewable Tablets

Product Name
硫糖铝咀嚼片
Approval Number
国药准字H41022549
Approval Date
Jul 16, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.